Science
Research
Projects
Publications
News
Team
Explorables
Contact
vaccination
Just published: Using smartphones to study vaccination decisions in the wild
N A Girardini
,
A Stopczynski
,
O Baranov
,
C Betsch
,
D Brockmann
,
S Lehmann
,
R Böhm
One of the most important tools available to limit the spread and impact of infectious diseases is vaccination. It is therefore important to …
Using smartphones to study vaccination decisions in the wild
N A Girardini
,
A Stopczynski
,
O Baranov
,
C Betsch
,
D Brockmann
,
S Lehmann
,
R Böhm
PLOS Digital Health 3(8): e0000550
One of the most important tools available to limit the spread and impact of infectious diseases is vaccination. It is therefore important to …
DOI
View
New paper out: Germany’s fourth COVID-19 wave was mainly driven by the unvaccinated
B F Maier
,
M Wiedermann
,
A Burdinski
,
P Klamser
,
M Jenny
,
C Betsch
,
D Brockmann
With about 65% of its citizens vaccinated at the time, Germany experienced a large wave of COVID-19 in the fall of 2021, regionally overburdening the …
Germany’s fourth COVID-19 wave was mainly driven by the unvaccinated
B F Maier
,
M Wiedermann
,
A Burdinski
,
P Klamser
,
M Jenny
,
C Betsch
,
D Brockmann
Nature Commun. Med 2., 116
While the majority of the German population was fully vaccinated at the time (about 65%), COVID-19 incidence started growing exponentially in October …
PDF
Cite
DOI
View
Die Pandemie wird durch fehlenden Impfschutz getrieben: Was ist zu tun?
B F Maier
,
M Wiedermann
,
A Burdinski
,
P Klamser
,
M Jenny
,
C Betsch
,
D Brockmann
Bericht (German)
PDF
Potential benefits of delaying the second mRNA COVID-19 vaccine dose
B F Maier
,
A Burdinski
,
A H Rose
,
F Schlosser
,
D Hinrichs
,
C Betsch
,
L Korn
,
P Sprengholz
,
M Meyer-Hermann
,
T Mitra
,
K Lauterbach
,
D Brockmann
arXiv:2102.13600
Vaccination against COVID-19 with the recently approved mRNA vaccines BNT162b2 (BioNTech/Pfizer) and mRNA-1273 (Moderna) is currently underway in a …
PDF
Cite
View
Preprint out: Potential benefits of delaying the second mRNA COVID-19 vaccine dose
B F Maier
,
A Burdinski
,
A H Rose
,
F Schlosser
,
D Hinrichs
,
C Betsch
,
L Korn
,
P Sprengholz
,
M Meyer-Hermann
,
T Mitra
,
K Lauterbach
,
D Brockmann
Molecular surveillance of measles and rubella in the WHO European Region: new challenges in the elimination phase
S Santibanez
,
J M Hübschen
,
M C Ben Mamou
,
M Muscat
,
K E Brown
,
R Myers
,
O Donoso Mantke
,
H Zeichhardt
,
D Brockmann
,
S V Shulga
,
C.P.Muller
,
P M O'Connor
,
M N Mulders
,
A Mankertz
Clinical Microbiology and Infection 23 516e523
The WHO European Region (EUR) has adopted the goal of eliminating measles and rubella but individual countries perform differently in achieving this …
PDF
Cite
DOI
View
Public health: This message must be herd
D Brockmann
Nature Human Behaviour 1 (0065)
Immunization against vaccine-preventable diseases not only protects the individual but also has a social benefit. A study now shows that communicating …
PDF
Cite
DOI
View
Cite
×